Allegria Therapeutics Secures USD 5.1 Million in Seed Extension Funding

Marco Zingaro Europe Legal Chronicle
Tagged:

Walder Wyss has advised Allegria Therapeutics. Allegria Therapeutics, a biotechnology company based in Basel, Switzerland, has completed a seed extension funding round, raising USD 5.1 million….

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here